GLOMERULONEPHRITIS

Clinical trials for GLOMERULONEPHRITIS explained in plain language.

Never miss a new study

Get alerted when new GLOMERULONEPHRITIS trials appear

Sign up with your email to follow new studies for GLOMERULONEPHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Completed 1

New injection tested for rare kidney disease

Disease control Completed

This early-stage study tested the safety and effects of mezagitamab, an experimental injection, in 17 people with IgA nephropathy, a kidney disease. Participants received weekly injections for 8 weeks, then every 2 weeks for 16 weeks, while continuing their standard medications. …

Matched conditions: GLOMERULONEPHRITIS

Phase: PHASE1 • Sponsor: Takeda • Aim: Disease control

Last updated Mar 23, 2026 15:19 UTC

GLOMERULONEPHRITIS

Get alerted when new GLOMERULONEPHRITIS trials appear

New injection tested for rare kidney disease